Healthcare Infection Control Practices Advisory Committee (HICPAC), 23965-23966 [2020-09259]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Pages 23965-23966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09259]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2020-0047]


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public, limited only by audio phone lines available. The public is 
welcome to listen to the meeting by teleconference; 200 teleconference 
lines are available, and registration is required.

DATES: The meeting will be held on May 15, 2020, 3 p.m.-4:30 p.m., EDT.
    Written comments must be received on or before May 13, 2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0047 by any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Koo-Whang Chung, M.P.H., Centers for Disease Control 
and Prevention, 1600 Clifton Road NE, MS H16-3, Atlanta, Georgia 30329-
4027, Attn: HICPAC meeting.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov. 
Written comments received in advance of the meeting will be included in 
the official record of the meeting.
    Meeting information: The teleconference access is 1-800-857-4261, 
and the passcode is 8109424. Registration is required. Interested 
parties may register at https://www.cdc.gov/hicpac.

FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE, MS H16-3, Atlanta, Georgia 30329-4027; Telephone: 404-639-
4000; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health 
and Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating of 
CDC guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.

Public Participation

    Procedure for Public Comment: Time will be available for public 
comment. Members of the public who wish to provide public comments 
should plan to attend the public comment session at the start time 
listed. Please note that the public comment period may end before the 
time indicated, following the last call for comments.
    Written Public Comment: The public is welcome to submit written 
comments in advance of the meeting. Comments should be submitted on or 
before May 13, 2020. All requests must contain the name and 
organizational affiliation of the speaker, as well as the topic being 
addressed. Written comments should not exceed one single-spaced typed 
page in length. Written comments received in advance of the meeting 
will be included in the official record of the meeting. Comments 
received, including attachments and other supporting materials, are 
part of the public record and are subject to public disclosure. 
Comments will be posted on https://www.regulations.gov. Therefore, do 
not include any information in your comment or supporting materials 
that you consider confidential or inappropriate for public disclosure. 
If you include your name, contact

[[Page 23966]]

information, or other information that identifies you in the body of 
your comments, that information will be on public display. CDC will 
review all submissions and may choose to redact, or withhold, 
submissions containing private or proprietary information such as 
Social Security numbers, medical information, inappropriate language, 
or duplicate/near duplicate examples of a mass-mail campaign. CDC will 
carefully consider all comments submitted to the docket.
    Matters to be Considered: The agenda will include updates from the 
HICPAC Long-term Care/Post-acute Care Workgroup related to COVID-19 in 
U.S. long-term care facilities. Agenda items are subject to change as 
priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

    Dated: April 27, 2020.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-09259 Filed 4-28-20; 9:45 am]
 BILLING CODE 4163-18-P